[18F]FDG-PET as an imaging biomarker to NMDA receptor antagonist-induced neurotoxicity

Positron emission tomography (PET) is an effective tool for noninvasive examination of the body and provides a range of functional information. PET imaging with [(18)F]fluoro-2-deoxy-d-glucose ([(18)F]FDG) has been used to image alterations in glucose metabolism in brain or cancer tissue in the fiel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicological sciences Jg. 133; H. 1; S. 13
Hauptverfasser: Shirakawa, Takafumi, Mitsuoka, Keisuke, Kuroda, Kanae, Miyoshi, Sosuke, Shiraki, Katsuhisa, Naraoka, Hitoshi, Noda, Akihiro, Fujikawa, Akihiko, Fujiwara, Michio
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 01.05.2013
Schlagworte:
Animals
Biomarkers - metabolism
Cell Death - drug effects
Dizocilpine Maleate - toxicity
Dose-Response Relationship, Drug
Excitatory Amino Acid Antagonists - toxicity
Female
Fluorodeoxyglucose F18
Glucose - metabolism
Gyrus Cinguli - diagnostic imaging
Gyrus Cinguli - metabolism
Gyrus Cinguli - pathology
Macaca fascicularis
Neurons - diagnostic imaging
Neurons - metabolism
Neurons - pathology
Neurotoxicity Syndromes - diagnostic imaging
Neurotoxicity Syndromes - metabolism
Neurotoxicity Syndromes - pathology
Positron-Emission Tomography - methods
Rats
Rats, Sprague-Dawley
Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors
ISSN:1096-0929
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Positron emission tomography (PET) is an effective tool for noninvasive examination of the body and provides a range of functional information. PET imaging with [(18)F]fluoro-2-deoxy-d-glucose ([(18)F]FDG) has been used to image alterations in glucose metabolism in brain or cancer tissue in the field of clinical diagnosis but not in the field of toxicology. A single dose of N-methyl-d-aspartate (NMDA) receptor antagonist induces neuronal cell degeneration/death in the rat retrosplenial/posterior cingulate (RS/PC) cortex region. These antagonists also increase local cerebral glucose utilization. Here, we examined the potential of [(18)F]FDG-PET as an imaging biomarker of neurotoxicity induced by an NMDA receptor antagonist, MK-801. Using [(18)F]FDG-PET, we determined that increased glucose utilization involved the neurotoxicity induced by MK-801. The accumulation of [(18)F]FDG was increased in the rat RS/PC cortex region showing neuronal cell degeneration/death and detected before the onset of neuronal cell death. This effect increased at a dose level at which neuronal cell degeneration recovered 24h after MK-801 administration. Scopolamine prevented the neurotoxicity and [(18)F]FDG accumulation induced by MK-801. Furthermore, in cynomolgus monkeys that showed no neuronal cell degeneration/death when treated with MK-801, we noted no differences in [(18)F]FDG accumulation between test and control subjects in any region of the brain. These findings suggest that [(18)F]FDG-PET, which is available for clinical trials, may be useful in generating a predictive imaging biomarker for detecting neurotoxicity against NMDA receptor antagonists with the same pharmacological activity as MK-801.
ISSN:1096-0929
DOI:10.1093/toxsci/kft036